What 4 Analyst Ratings Have To Say About Outset Medical
Portfolio Pulse from Benzinga Insights
Outset Medical (NASDAQ:OM) has received four analyst ratings in the last quarter, with one being somewhat bullish and three indifferent. The average 12-month price target for the company is $23.25, representing a 3.12% decrease from the previous average price target of $24.00.
August 24, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Outset Medical has received mixed analyst ratings, with a somewhat bullish and three indifferent ratings. The average 12-month price target has decreased by 3.12%.
The mixed analyst ratings and the decrease in the average 12-month price target could lead to uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100